We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.025 | -0.16% | 15.375 | 354,313 | 09:00:15 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 15.25 | 15.50 | 15.50 | 15.25 | 15.25 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | EUR 56.04M | EUR 16.12M | EUR 0.0237 | 6.54 | 104.78M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 10:09:48 | O | 11,539 | 15.495 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 07/3/2025 | 07:00 | UK RNS | hVIVO PLC Director/PDMR Shareholding |
| 27/2/2025 | 07:00 | UK RNS | hVIVO PLC Acquisition of Cryostore for up to £3.2m |
| 17/2/2025 | 17:54 | ALNC |  IN BRIEF: hVIVO signs GBP2 million deal as aims to progress hMPV care |
| 17/2/2025 | 07:00 | UK RNS | hVIVO PLC £2m hMPV characterisation study contract |
| 05/2/2025 | 07:00 | UK RNS | hVIVO PLC Shionogi reports positive RSV trial results |
| 03/2/2025 | 16:37 | ALNC | hVIVO wins contract for RSV drug human trial for Inhalon Biopharma |
| 03/2/2025 | 07:00 | UK RNS | hVIVO PLC RSV contract signed with Inhalon Biopharma |
| 31/1/2025 | 13:24 | UK RNS | hVIVO PLC Holding(s) in Company |
| 31/1/2025 | 07:00 | UK RNS | hVIVO PLC Holding(s) in Company |
| 29/1/2025 | 11:42 | ALNC | hVIVO eyes double-digit revenue rise, announces new acquisition |
Hvivo (HVO) Share Charts1 Year Hvivo Chart |
|
1 Month Hvivo Chart |
Intraday Hvivo Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 19/3/2025 | 10:08 | hVIVO plc | 9,464 |
| 27/2/2025 | 07:11 | Profit warning now likely | 10 |
| 15/8/2024 | 16:32 | HVIVO (litter free) | 56 |
| 10/4/2024 | 06:01 | HVIVO (litrer free) | 2 |
| 26/10/2022 | 07:49 | hVIVO plc | 2,750 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 10:09:49 | 15.50 | 11,539 | 1,787.97 | O |
| 09:50:57 | 15.50 | 2,000 | 309.90 | O |
| 09:41:40 | 15.30 | 8,601 | 1,315.95 | O |
| 09:40:49 | 15.31 | 23,085 | 3,534.31 | O |
| 09:27:18 | 15.31 | 1 | 0.15 | O |
| Top Posts |
|---|
Posted at 19/3/2025 08:20 by Hvivo Daily Update Hvivo Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker HVO. The last closing price for Hvivo was 15.40p.Hvivo currently has 680,371,877 shares in issue. The market capitalisation of Hvivo is £105,457,641. Hvivo has a price to earnings ratio (PE ratio) of 6.54. This morning HVO shares opened at 15.25p |
Posted at 12/3/2025 09:50 by troutisout Who cares about Friel? Just you and a couple of other posters who cannot seem to let go...CF last sold in July at 29p, the share price remained around that level for 3-4 months, his selling hardly precipitated an immediate crash.I have been on the end of unenforced large sellers and the share price can drop massively as they get out and that often wipes out investors who are on margin or with stop losses, CF sold and now the price is a lot lower, that is investment picking the right time to buy and more importantly the right time to sell. I would say the way the share price reacted to CFs sale that he did his best to mitigate any fall and he did sell his shares at 29p so he must have created liquidity or at least have buyers wanting to pay that price for them. Since then we have had IIs buying and others selling and the share price dropped due to worries over the slippage in orders. I think this is undervalued at the moment and once the market jitters abate this will go back into the 20's |
Posted at 10/3/2025 17:35 by sikhthetech Options would be taken at the highest price the execs think they can get.I think the CEO believes the current price was right. It then follows the forthcoming newsflow is likely to disappoint again and share price will fall. As per my assertion, we're closer to my 10p target than the 30p....as predicted. The rampers have been proven wrong. 1gw and his mates were ramping at 30p... they keep changing the metric to whatever looks the best. No consistency.... Don't take my word for it... Look at Byot 10p to 0.1p, down 99.9% delisted!! 1gw claimed the house broker was being 'conservative' despite the company themselves showing sales had slowed. sikhthetech - 11 Dec 2024 - 12:32:22 - 8962 of 9143 hVIVO plc - HVO Trout, "At 30p and with £62m revs expected the mkt cap was £200m (just over 3 times revs). So does that mean current price giving us £150m mkt cap is pricing in just under £50m revs for 2025? There seems to be a good cushion there" Wrong. The expectations were the same when the share price was 10p, only 2 years ago, weren't they? The share price rose on the back of the company being talked up, CEO awarded the huge >7m options, back dated a year and exercise from < 2 months time, in FEBRUARY. A new red flag is the fy2024 TU has been pushed back to Feb (coincidence!!!). I'd expect the share price to be nearer to 10p than 30p. The newsflow here has been as predicted. |
Posted at 10/3/2025 10:03 by 1gw A few observations on the options.Max award was 7,227,273. 25% vested on service and 75% on performance, with a single performance criterion being CAGR TSR over 3 years from an 11p reference share price. It was not clear how long Mo had to exercise the options once they vested. Usually I think a company will say they are exercisable between dates A & B (A being the vesting date and B often being several years after they vest) but in the original notice and in the annual report they give only the vesting date (23/2/25). My guess is therefore he had a relatively short period to exercise them. Afaics he exercised all that had vested which was 89% of the max amount, or all the service-related amount plus 85% of the max performance-related amount. To hit the 85% of performance-related vesting I think the CAGR TSR must have been calculated as 20.7%. This was from an 11p reference share price. Stephen Pinkerton has a harder job to get a decent proportion of his award, which is measured against a 17p reference price with a 10% CAGR TSR threshold and has a vesting date of 1 February 2026. MO's current options have a broader set of performance criteria, being 40% CAGR TSR, 40% CAGR EBITDA and 20% ESG/sustainability (again being 75% of total award). They are measured over 3 years ending 31 December 2026 and will vest on 30 June 2027. TSR element has a 10% CAGR hurdle and 18% needed for max payout but reference share price and measurement period for calculating achieved shareprice are not clear in the original announcement. I would say the incentive scheme appears to be doing its job. Having exercised the first award Mo now has more equity skin in the game. Although there have been a couple of recent acquisitions, it doesn't look as though MO took any unreasonably risky decisions in order to try to juice the shareprice ahead of the vesting date, although it's not entirely clear what the measurement period for the final shareprice calculation was. Both Mo and Stephen are incentivised to get the shareprice higher over the next couple of years, and Mo's performance criteria broadening out to include EBITDA provides a bit of a check on making decisions which favour short-term shareprice growth over longer-term earnings growth. Having said that, shareprice and EBITDA criteria still provide something of an incentive to make "risky" acquisitions which boost EBITDA (amortisation of the acquisition is excluded) and are well-received in the short-term but may expose the business in the medium-term. It is the board's job to ensure that risks are properly considered and staggering the performance periods for CEO and CFO awards provides some mitigation here. |
Posted at 27/2/2025 10:05 by pogue There have been a lot of changes at HVO with add ons and upgrades recently it is becoming a bigger CRO. Cross selling is the way to make money as a CRO offering more services and becoming a one stop shop means you take more of the client's R&D budget, getting a client is the hard bit extracting more money from them is much easier hence the 2 new add ons will bring more customers and more income. HVO following a well trodden path. Just sit and watch this grow the share price will take care of itself, I think its a great long term investment at such a low multiple of earnings compared to its peers. The share price is stupidly low for a debt free profit generating company with lots of cash in the bank. The market will work it out at some point or someone will offer a premium to buy it. |
Posted at 25/2/2025 15:49 by sikhthetech There you go, getting close to the 10p.Amazing how trout/1gw/pierre/sup Moved on to the next one, no doubt. Oh, Nexn is busy.... That's down 25% in a week!!! sikhthetech - 11 Dec 2024 - 12:32:22 - 8962 of 9143 hVIVO plc - HVO Trout, "At 30p and with £62m revs expected the mkt cap was £200m (just over 3 times revs). So does that mean current price giving us £150m mkt cap is pricing in just under £50m revs for 2025? There seems to be a good cushion there" Wrong. The expectations were the same when the share price was 10p, only 2 years ago, weren't they? The share price rose on the back of the company being talked up, CEO awarded the huge >7m options, back dated a year and exercise from < 2 months time, in FEBRUARY. A new red flag is the fy2024 TU has been pushed back to Feb (coincidence!!!). I'd expect the share price to be nearer to 10p than 30p. The newsflow here has been as predicted. |
Posted at 14/1/2025 21:18 by protrader3 There is no doubt whatsoever that Cathal would have had better knowledge of HVO than any research Octopus could have carried out. Cathal dumped his entire holding just under 30p Octopus are averaging down with a 40 percent loss with share price sitting at 17p.I dread ro think where the share price would be if it wasn't for Octopus. It's quite frightening actually. A poor T/U in February and this share price is going to tank even further. Mo really needs to pull something special out of the bag here. |
Posted at 08/1/2025 15:38 by sikhthetech Yes, getting closer to my 10p target..Where are the 30p brigade? Trout, 1gw, Pierre, Supernumerary etc etc Surely given these have fallen 40%, they are loading up???? I see FAB was also pumped/dumped, as predicted. sikhthetech - 11 Dec 2024 - 12:32:22 - 8962 of 9143 hVIVO plc - HVO Trout, "At 30p and with £62m revs expected the mkt cap was £200m (just over 3 times revs). So does that mean current price giving us £150m mkt cap is pricing in just under £50m revs for 2025? There seems to be a good cushion there" Wrong. The expectations were the same when the share price was 10p, only 2 years ago, weren't they? The share price rose on the back of the company being talked up, CEO awarded the huge >7m options, back dated a year and exercise from < 2 months time, in FEBRUARY. A new red flag is the fy2024 TU has been pushed back to Feb (coincidence!!!). I'd expect the share price to be nearer to 10p than 30p. The newsflow here has been as predicted. |
Posted at 07/1/2025 17:10 by sikhthetech The share price is closer to 10p than 30p, isn't it?sikhthetech - 11 Dec 2024 - 12:32:22 - 8962 of 9143 hVIVO plc - HVO Trout, "At 30p and with £62m revs expected the mkt cap was £200m (just over 3 times revs). So does that mean current price giving us £150m mkt cap is pricing in just under £50m revs for 2025? There seems to be a good cushion there" Wrong. The expectations were the same when the share price was 10p, only 2 years ago, weren't they? The share price rose on the back of the company being talked up, CEO awarded the huge >7m options, back dated a year and exercise from < 2 months time, in FEBRUARY. A new red flag is the fy2024 TU has been pushed back to Feb (coincidence!!!). I'd expect the share price to be nearer to 10p than 30p. The newsflow here has been as predicted. |
Posted at 31/12/2024 15:31 by sikhthetech There you go, the company newsflow has been as I predicted a year ago!!!sp was 25.5p when I posted the post... sp now at 20.5p. This is despite the supposedly huge new facility, huge buying by IIs, supposedly huge new contracts, supposedly huge potential!!!! I said I wouldn't buy because they are being talked up and I don't see the potential... Glad I didn't listen to 1gw and his mates ramping at 30p. sikhthetech - 02 Jan 2024 - 12:01:49 - 5733 of 9118 hVIVO plc - HVO chica, Baldrick is right, those who traded have made more than those who just held. Facts: Look at the chart and actual sps. Last year, in Feb, the share price was 21.5p Also, hardly any movement year to year. Out of last 4 years, 3 years the share price ended the year 23-24p. The other, Dec 2022, which was whilst Mo was CEO, it was 10.2p. Dec 2020 22p Dec 2021 24p Dec 2022 10.20p Feb 2023 21.5p, Dec 2023 23.75p The current share price is still lower than it was 2.5yrs ago, when I 1st looked at these - coincidentally following a media tip!. The share price has been falling during the year to move back towards 23p-24p by year end. Media tips and the share price rises again only to fall again. I have traded these in the past but don't currently hold as I believe they are hyped. Mo has huge options which are due to exercise in a year, so this is being talked up. £173m Mcap for a company with expected £60m revenues!! |
Posted at 20/11/2024 17:56 by malcolmz1 The problem is HVO share price is about to test 18p. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
